Key design considerations on comparative clinical efficacy studies for biosimilars

Adalimumab as an example

Read more

The global development of a biosimilar product is a methodologically complex affair, lined with potential design pitfalls and operational missteps to be avoided. Read this article for design options for clinical efficacy studies.

Want to learn more about Worldwide Clinical Trials?